U.S. Markets open in 28 hrs, 15 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,220.96 | 32.73 | 0.29% |
| NASDAQ | 2,255.88 | -3.16 | -0.14% |
| S&P 500 | 1,242.31 | 5.48 | 0.44% |
| Day Low 10:54 AM EDT | 9.73 | |
|---|---|---|
| Day High 09:33 AM EDT | 9.85 |
|
| Range | 0.12 | |
| Volume | 119,358 | |
| 30-Day Avg. Vol. | 53,000 |
|
| Difference | 125.20% | |
| Market Cap. | 1.49 B | |
| Change | 0 | |
| Shares Out. | 21.72 M | |
| Percent Traded | 0.08% | |
| Revenue (LFY) | 23.76 M | |
| Earnings (TTM) | 10.75 M | |
| Next Earnings | 8/13/08 |
|
| EPS (TTM) | 0.52262 |
| 52-Wk Low 3/17/08 | 7.29 | |
|---|---|---|
| 52-Wk High 10/31/07 | 22.75 |
|
| Range | 15.46 | |
| Prev. Close 9/4/08 | 9.80 | |
| Today's Open | 9.75 | |
| Change | -0.51% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | — | |
| P/E Ratio (TTM) | 18.49 | |
| P/E Ratio (Fwd.) | — |
3SBio wants to find a cure for a wide spread of ailments, including cancer and viral and autoimmune diseases. The biopharmaceutical company develops protein-based products for treating diseases in nephrology, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | 0.121 3/31/08 | 0.13 3/31/08 |
0.009
Beat
|
| Last Quarter | 0.122 6/30/08 | 0.13 6/30/08 |
0.008
Beat
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 8.60 M | 23.76 M |
| Gross Profit | 7.83 M | 21.13 M |
| Operating Income | 2.19 M | 6.40 M |
| Net Income | 2.80 M | 10.75 M |
